EGFR and cancer: The data retrieved from the KEGG indicated that these genes are enriched in signaling pathways closely associated with LUAD, including proteoglycans in cancer, Rap1 signaling pathway, calcium signaling pathway, EGFR tyrosine kinase inhibitor resistance, focal adhesion, and PI3K-Akt signaling pathway (Figure 7C).